Mon.Nov 18, 2024

article thumbnail

With rising cancer rates in younger adults, experts emphasize better tests

STAT

Cancer cases are on the rise among people under 50 — and researchers aren’t sure why. A recent study by the American Cancer Society found that 17 out of 34 cancer types were increasing among younger people.  At the Milken Institute’s Future of Health Summit on Thursday, researchers and health care executives talked about efforts to detect cancers earlier, save lives, and get to the root of why cancers have begun to rise in this population.

299
299
article thumbnail

Cytisine pill could be added to stop smoking guidelines

The Pharmacist

NICE is consulting on a proposal to add cytisine as a treatment option to its stop smoking guidelines. This proposal follows a review of recent evidence which suggests patients who received cytisine were 30% more likely to not smoke for six months or longer, when compared to placebo or no medication. The drug was made […] The post Cytisine pill could be added to stop smoking guidelines appeared first on The Pharmacist.

119
119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: AHA 2024: First, a call for prevention. Then a spotlight on obesity drugs

STAT

CHICAGO — This year’s scientific sessions on the latest research in cardiovascular disease began not with the buzzy new obesity drugs but with a sobering look at progress stalling or even reversing in common chronic illnesses. The overture to the American Heart Association’s conference, coming as the organization celebrates its 100th year, began with Valentin Fuster of Mount Sinai Hospital lamenting the predicted shift in overall cardiovascular disease burden,  worsenin

Hospitals 296
article thumbnail

Local systems must involve community pharmacy to improve population health

The Pharmacist

Local systems need to talk to community pharmacies about how they can help improve population health, a local pharmaceutical committee (LPC) leader has urged. Pharmacies are well placed to provide anecdotal feedback about their local communities and what they need to their local systems, Shilpa Shah said at the Public Policy Projects (PPP) Integrated Health […] The post Local systems must involve community pharmacy to improve population health appeared first on The Pharmacist.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Can drugs be blockbusters without relying on US sales?

Drug Patent Watch

The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S. sales.

98

More Trending

article thumbnail

Reshaping pharma safety with active packaging innovations

Express Pharma

In pharmaceutical packaging, where quality and safety are requisites for a shelf-stable formulation, Cilicant has understood this concern very well and is committed to providing the right solutions to protect the formulations from the harmful effects of moisture and oxygen, which are well-known factors affecting stability. Over the years, CILICANT has established itself as an innovative manufacturer of active packaging solutions with notable patented technologies.

article thumbnail

The Future of Generic Drug Development in Emerging Markets

Drug Patent Watch

The pharmaceutical industry is undergoing a significant shift, with emerging markets offering the next growth opportunity. This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs.

article thumbnail

Lupin re-launches Humrahi with focus on diabetes and heart health

Express Pharma

Global pharma major Lupin (Lupin) announced the re-launch of Humrahi at the Research Society for the Study of Diabetes in India (RSSDI) conference in New Delhi. Humrahi is now enhanced with comprehensive support for both diabetes and heart health. With diabetes and cardiovascular diseases ranking among the top health challenges globally, Humrahi represents a critical innovation that combines extensive support for diabetes management along with robust care strategies for heart health.

Diabetes 101
article thumbnail

The first MASH drug could open the door for others — including GLP-1s

PharmaVoice

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive edge.

162
162
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Antibacterial peptides instrumental in efficiency against resistant bacteria

Pharmafile

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, when paired with material equipped with antibacterial peptides, can regain susceptibility to antibiotics. The study, conducted in a laboratory environment, concluded that antibiotics – such as oxacillin – could achieve an increase in their bactericidal […] The post Antibacterial peptides instrumental in efficiency against resistant bacteria appeared first

59
article thumbnail

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

PharmaVoice

Merck’s acquisition of Modifi Biosciences bucks common M&A trends in pharma.

147
147
article thumbnail

FDA endorses speedy approval path for Regenxbio Duchenne gene therapy

BioPharma Dive

The agency's openness to a targeted pivotal study shows it’s still willing to consider accelerated clearance for Duchenne gene therapies despite questions about their effectiveness.

132
132
article thumbnail

Teva and Immunai partner to improve clinical decision making

Pharma Times

The companies will focus on mechanisms of action, dose selection and biomarker analyses

124
124
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest

BioPharma Dive

Phase 1 data indicate Intellia’s medicine could be a powerful treatment for a cardiac form of ATTR amyloidosis. But rival drugs are further ahead.

114
114
article thumbnail

Neurogene falls again on Rett gene therapy side effects

pharmaphorum

Neurogene has halted patient enrolment in the high-dose arm of its trial of Rett syndrome gene therapy, sparking another run on its shares

105
105
article thumbnail

AbbVie’s Elahere wins European approval for certain ovarian cancers

Pharmaceutical Technology

The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.

105
105
article thumbnail

AI could 'cut ECG result wait times and speed up treatment'

pharmaphorum

Using AI-powered PanEcho software for screening ECGs could deliver results more quickly and allow treatment to be started earlier.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Reducing variability in gene expression: bottlenecks and solutions

BioPharma Dive

Explore solutions to reduce variability in gene expression during cell line development.

98
article thumbnail

Grifols linked to €7bn takeover offer from Brookfield

pharmaphorum

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.A report in Spanish newspaper El Confidencial suggests that Brookfield is preparing to make a bid to take a 65% controlling stake in the drugmaker for €10.50 per share, worth around €7 billion ($7.4 billion).

105
105
article thumbnail

AHA 2024: Plozasiran demonstrates promising Phase III results in FCS adults

Pharmaceutical Technology

During AHA 2024, data were presented from the Phase III trial of plozasiran targeting adults with genetically or clinically diagnosed FCS,

98
article thumbnail

Syndax gets FDA okay for first-in-class leukaemia drug

pharmaphorum

Shortly after a disappointing trial readout for Syndax's menin inhibitor Revuforj in one form of leukaemia, the company has claimed FDA approval in another

104
104
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Sandoz’s Afqlir gains EC marketing authorisation for retinal diseases

Pharmaceutical Technology

The EC has granted marketing authorisation for Sandoz's Afqlir for the treatment of various retinal diseases.

98
article thumbnail

AbbVie bags EU nod for key drug from ImmunoGen takeover

pharmaphorum

AbbVie's Elahere is approved in EU, ending a 10-year wait for a new therapy for platinum-resistant ovarian cancer.

98
article thumbnail

FDA approves Syndax’s Revuforj to treat leukaemia

Pharmaceutical Technology

The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.

97
article thumbnail

Your Roadmap to Category Management Success in 2025

Pharma and Life Sciences Blog

Your Roadmap to Category Management Success in 2025 priyanka.katke… Mon, 11/18/2024 - 17:57 Your Roadmap to Category Management Success in 2025 2025 will feel familiar, in some regards. The procurement and supply chain category management landscape will remain turbulent, with geopolitical tensions, worries over fresh tariffs and rising costs and supply chain disruptions posing significant challenges.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.